Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 2 | $0.05 | $0.06 | $0.06 |
Q2 2024 | 2 | $0.19 | $0.19 | $0.19 |
Q3 2024 | 1 | $0.19 | $0.19 | $0.19 |
Q4 2024 | 4 | $0.27 | $0.30 | $0.27 |
Q1 2025 | 3 | $0.17 | $0.18 | $0.17 |
Q2 2025 | 2 | $0.22 | $0.24 | $0.23 |
Q3 2025 | 2 | $0.24 | $0.26 | $0.25 |
Q4 2025 | 2 | $0.34 | $0.36 | $0.35 |
Q1 2026 | 1 | $0.26 | $0.28 | $0.27 |
Q2 2026 | 1 | $0.34 | $0.36 | $0.35 |
Q3 2026 | 1 | $0.37 | $0.39 | $0.38 |
Q4 2026 | 1 | $0.49 | $0.53 | $0.51 |
AdaptHealth Corp. last posted its earnings results on Tuesday, November 5th, 2024. The company reported $0.15 earnings per share for the quarter, missing analysts' consensus estimates of $0.17 by $0.02. The company had revenue of 805.86 M for the quarter and had revenue of 3.20 B for the year. AdaptHealth Corp. has generated $-5 earnings per share over the last year ($-5.31 diluted earnings per share) and currently has a price-to-earnings ratio of -6.44. AdaptHealth Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/05/2024 | Q3 2024 | $0.17 | $0.16 | -0.01 | $809.32 M | $805.86 M |
08/06/2024 | Q2 2024 | $0.19 | $0.13 | -0.06 | $802.62 M | $805.98 M |
05/07/2024 | Q1 2024 | $0.06 | -$0.02 | -0.08 | $792.50 M | |
02/27/2024 | Q4 2023 | $0.20 | -$1.91 | -2.11 | $858.23 M | |
11/07/2023 | Q3 2023 | $0.19 | -$3.37 | -3.56 | $796.60 M | $804.03 M |
08/08/2023 | Q2 2023 | $0.11 | $0.10 | -0.01 | $765.17 M | $793.29 M |
05/09/2023 | Q1 2023 | $0.08 | $0.11 | 0.03 | $744.63 M | |
02/28/2023 | Q4 2022 | -$0.01 | $780.28 M | |||
11/08/2022 | Q3 2022 | $0.31 | $0.10 | -0.21 | $737.93 M | $557.65 M |
08/09/2022 | Q2 2022 | $0.28 | $0.09 | -0.19 | $724.22 M | $727.61 M |
05/10/2022 | Q1 2022 | $0.21 | $0.28 | 0.07 | $706.20 M | |
03/01/2022 | Q4 2021 | $0.16 | $702.11 M | |||
11/09/2021 | Q3 2021 | $0.40 | $638.74 M | $653.29 M | ||
08/06/2021 | Q2 2021 | $0.56 | $574.03 M | $617.02 M | ||
05/10/2021 | Q1 2021 | -$0.04 | $482.12 M | |||
03/16/2021 | Q4 2020 | -$0.47 | $348.43 M | |||
11/06/2020 | Q3 2020 | -$0.04 | $265.25 M | $284.41 M | ||
08/06/2020 | Q2 2020 | $0.10 | $196.28 M | $232.12 M | ||
05/08/2020 | Q1 2020 | -$0.00 | $191.44 M | |||
03/06/2020 | Q4 2019 | -$0.11 | $149.54 M |
AdaptHealth Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates.
The conference call for AdaptHealth Corp.'s latest earnings report can be listened to online.
The conference call transcript for AdaptHealth Corp.'s latest earnings report can be read online.
AdaptHealth Corp. (:AHCO) has a recorded annual revenue of $3.20 B.
AdaptHealth Corp. (:AHCO) has a recorded net income of $3.20 B. AdaptHealth Corp. has generated $-5.32 earnings per share over the last four quarters.
AdaptHealth Corp. (:AHCO) has a price-to-earnings ratio of -6.44 and price/earnings-to-growth ratio is -0.09.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED